PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.84
2 yrs 6 m
0%
824.90 Crs
NIL
Large Growth
10.27
SIP 100 & Lumpsum 500
BSE HEALTH CARE - TRI
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk